Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome
- 11 October 2014
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 15 (2-3) , 500-507
Abstract
Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive loss of cognitive function. One of the pathological hallmarks of AD is the formation of neurofibrillary tangles composed of abnormally hyperphosphorylated tau protein, but global deregulation of protein phosphorylation in AD is not well analyzed. Here, we report a pilot investigation of AD phosphoproteome by titanium dioxide enrichment coupled with high resolution LC‐MS/MS. During the optimization of the enrichment method, we found that phosphate ion at a low concentration (e.g. 1 mM) worked efficiently as a nonphosphopeptide competitor to reduce background. The procedure was further tuned with respect to peptide‐to‐bead ratio, phosphopeptide recovery, and purity. Using this refined method and 9 h LC‐MS/MS, we analyzed phosphoproteome in one milligram of digested AD brain lysate, identifying 5243 phosphopeptides containing 3715 nonredundant phosphosites on 1455 proteins, including 31 phosphosites on the tau protein. This modified enrichment method is simple and highly efficient. The AD case study demonstrates its feasibility of dissecting phosphoproteome in a limited amount of postmortem human brain. All MS data have been deposited in the ProteomeXchange with identifier PXD001180 (http://proteomecentral.proteomexchange.org/dataset/PXD001180).Keywords
Funding Information
- NIH (R21AG039764)
- Arizona Department of Health Services (211002)
- Arizona Biomedical Research Commission (4001)
- Michael J. Fox Foundation
- ALSAC
- NIH Cancer Center Support (P30CA021765)
This publication has 44 references indexed in Scilit:
- Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer’s disease and age-matched control brainsClinical Proteomics, 2013
- Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary DegenerationJournal of Alzheimer’s Disease, 2012
- Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human BrainsJournal of Proteome Research, 2012
- Rapid and Reproducible Single-Stage Phosphopeptide Enrichment of Complex Peptide Mixtures: Application to General and Phosphotyrosine-Specific Phosphoproteomics ExperimentsAnalytical Chemistry, 2011
- Proteomics Analysis Reveals Novel Components in the Detergent-Insoluble Subproteome in Alzheimer’s DiseaseJournal of Proteome Research, 2009
- Large-scale phosphorylation analysis of mouse liverProceedings of the National Academy of Sciences, 2007
- Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling NetworksCell, 2006
- Immunoaffinity profiling of tyrosine phosphorylation in cancer cellsNature Biotechnology, 2005
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- A systematic approach to the analysis of protein phosphorylationNature Biotechnology, 2001